???pagination.result.count???
???pagination.result.page???
1
Characterization of amino acid transport system L in HTB-41 human salivary gland epidermoid carcinoma cells. , Park NS., Anticancer Res. January 1, 2008; 28 (5A): 2649-55.
Site-directed mutagenesis of cysteine residues of large neutral amino acid transporter LAT1. , Boado RJ., Biochim Biophys Acta. September 15, 2005; 1715 (2): 104-10.
Transport of a neurotoxicant by molecular mimicry: the methylmercury-L-cysteine complex is a substrate for human L-type large neutral amino acid transporter (LAT) 1 and LAT2. , Simmons-Willis TA., Biochem J. October 1, 2002; 367 (Pt 1): 239-46.
Characterization of the system L amino acid transporter in T24 human bladder carcinoma cells. , Kim DK., Biochim Biophys Acta. September 20, 2002; 1565 (1): 112-21.
Identification of a membrane protein, LAT-2, that Co-expresses with 4F2 heavy chain, an L-type amino acid transport activity with broad specificity for small and large zwitterionic amino acids. , Pineda M., J Biol Chem. July 9, 1999; 274 (28): 19738-44.
Identification of SLC7A7, encoding y+LAT-1, as the lysinuric protein intolerance gene. , Torrents D., Nat Genet. March 1, 1999; 21 (3): 293-6.
4F2 ( CD98) heavy chain is associated covalently with an amino acid transporter and controls intracellular trafficking and membrane topology of 4F2 heterodimer. , Nakamura E., J Biol Chem. January 29, 1999; 274 (5): 3009-16.